# Arlington Capital Partners acquires majority stake in Riverpoint Medical

Arlington Capital Partners has acquired a majority interest in Riverpoint Medical, a developer and manufacturer of advanced sutures, implantables, and surgical devices. The transaction was advised by The Walden Group.

- Type: Acquisition
- Announced: 2019-06-27
- Where: Portland, Oregon, United States
- Status: completed
- Products: bioabsorbable sutures, high-strength fiber implantables, cordless surgeon headlights, brachytherapy devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Arlington Capital Partners](https://endata.com/companies/20929.md) (acquirer)
- [Riverpoint Medical](https://endata.com/companies/32149.md) (target)

## Sources

- [waldenmed.com](https://www.waldenmed.com/blog-post/walden-group-advises-riverpoint-medical-llc-partnership-arlington-capital-partners-helps-guide-transaction-successful-closing/), 2019-07-22: "The Walden Group, Inc. is pleased to announce that Arlington Capital Partners has acquired a majority interest in its client, Riverpoint Medical, LLC."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.